Table 2.

Primary and main secondary outcomes at 12 months

	Standard	Low	Difference in change (p =)
MOCA
N	12	15
Baseline	22.5 (17.8–25.8)	25.0 (17.0–26.0)
12 months	23.5 (16.5–27.0)	21.0 (15.0–25.0)	0.449
Change from baseline, p	1.0 (-2.8–3.0) p = 0.755	2.0 (-1.0–4.0) p = 0.047
HADS Depression
N	12	15
Baseline	4.5 (3.0–6.8)	4.0 (3.0–7.0)
12 months	5.0 (3.3–5.0)	5.0 (4.0–7.0)	0.236
Change from baseline, p	-0.5 (-2.0–2.8) p = 0.521	0.0 (-3.0–2.0) p = 0.503
HADS Anxiety
N	12	15
Baseline	2.5 (0.3–6.5)	3.0 (1.0–4.0)
12 months	2.5 (1.0–6.0)	4.0 (1.0–7.0)	0.704
Change from baseline, p	-0.5 (-1.0–1.8) p = 0.834	0.0 (-3.0–1.0) p = 0.194
AQOL
N	9	12
Baseline	47.0 (33.5–52.0)	46.0 (41.5–51.5)
12 months	47.0 (41.5–55.0)	47.5 (37.5–52.8)	0.66
Change from baseline, p	-1.0 (-10.0–2.0) p = 0.326	-1.0 (-9.5–8.0) p = 0.859
HD Recovery time
N	9	11
Baseline (hours)	4 (2–18)	3 (2–6)
12 months (hours)	8 (3–12)	4 (2–8)	0.67
Change from baseline (hours), p	0 (-8–2) p = 0.397	0 (-1–4) p = 0.813

Data presented as median (IQR)

MoCA – Montreal Cognitive Assessment tool, CAM – Confusion Assessment Method, QoL – quality of life, ADL – activities of daily living, HADS – Hospital Anxiety and Depression Scale, HD – haemodialysis